Our target audience is 45 million U.S. adults: Current cigarette smokers and a sub-set of former smokers. They are all ready for HEMPYS™.

They’re very knowledgeable about the benefits of CBD and early adopters of CBD products.

A roadmap for fast growth.

We prioritize states with the highest percentage of smokers and no legal marijuana—or only medical marijuana. CBD is their only cannabis option.  HEMPYS™ is already winning loyal fans all across America.